Drug Shortage Report for AA-MEDROXY
Report ID | 144662 |
Drug Identification Number | 02267640 |
Brand name | APO-MEDROXY |
Common or Proper name | MEDROXY |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2021-08-24 |
Estimated end date | 2022-01-31 |
Actual end date | 2022-01-28 |
Shortage status | Resolved |
Updated date | 2022-01-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-08-27 | English | Compare |
v2 | 2021-08-27 | French | Compare |
v3 | 2021-12-09 | English | Compare |
v4 | 2021-12-09 | French | Compare |
v5 | 2022-01-31 | English | Compare |
v6 | 2022-01-31 | French | Compare |
Showing 1 to 6 of 6